Will Windtree have another short squeeze later today

**Windtree Therapeutics (WINT) is poised for another potential short squeeze later today**, and here's the analysis to support this conclusion:

1. **Recent Surge in Shares**: WINT has experienced a significant surge in its stock price, with a closing price of $0.55 and a trading volume of 1.6 million shares on July 1, 2025. This increased activity suggests heightened investor interest and potential momentum that could lead to a short squeeze.
2. **Short Interest and Ratio**: Although short interest data is not currently available, the high trading volume and recent price surge suggest that there may be significant short interest. A high short ratio, combined with the potential for further price appreciation, could trigger a short squeeze if short sellers need to cover their positions.
3. **Market Sentiment and Analysts' Outlook**: Analysts have provided a high price forecast for WINT, with an average target price of $180.54, ranging from a low of $4.04 to a high of $367.50. This positive sentiment could contribute to a short squeeze if investors rush to cover their short positions to capitalize on the predicted upside potential.
4. **Strategic Acquisitions and Financial Position**: WINT has recently announced strategic acquisitions and a non-binding letter of intent for the sale of its preclinical oncology platform, which could positively impact the company's financials and market perception, potentially leading to increased investor confidence and a short squeeze.

In conclusion, Windtree Therapeutics is likely to experience another short squeeze later today due to its recent surge in shares, the potential for increased investor confidence from strategic acquisitions, and the positive analyst outlook. However, it's important to note that short squeezes can be unpredictable and subject to rapid changes in market sentiment.